Ardsley Advisory Partners’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Buy
600,000
+175,000
+41% +$1.6M 0.55% 61
2026
Q1
$3.83M Buy
+425,000
New +$6.71M 0.58% 62
2025
Q4
Sell
-425,000
Closed -$6.23M 146
2025
Q3
$6.23M Buy
425,000
+25,000
+6% +$429K 0.96% 46
2025
Q2
$7.28M Buy
400,000
+100,000
+33% +$2.04M 1.19% 35
2025
Q1
$5.95M Buy
+300,000
New +$5.19M 1.38% 28
2020
Q4
Sell
-94,100
Closed -$225K 132
2020
Q3
$225K Sell
94,100
-3,000
-3% -$8.23K 0.05% 121
2020
Q2
$285K Buy
97,100
+22,500
+30% +$64.6K 0.07% 108
2020
Q1
$215K Hold
74,600
0.09% 81
2019
Q4
$298K Sell
74,600
-31,900
-30% -$139K 0.06% 118
2019
Q3
$474K Buy
106,500
+3,892
+4% +$16.3K 0.12% 94
2019
Q2
$397K Buy
102,608
+41,308
+67% +$182K 0.08% 103
2019
Q1
$233K Buy
61,300
+11,300
+23% +$39.9K 0.05% 112
2018
Q4
$120K Sell
50,000
-50,000
-50% -$248K 0.03% 95
2018
Q3
$621K Buy
100,000
+20,000
+25% +$115K 0.11% 90
2018
Q2
$361K Buy
+80,000
New +$399K 0.06% 127

Other funds holding ADMA